~~<i id='3E1FF87001'><strike id='3E1FF87001'><tt id='3E1FF87001'><pre id='3E1FF87001'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

leisure time

Wikipedia

author：focus 2025-08-26 23:47:17 - browse：29

The FDA has taken a big step in encouraging drug companies to include pregnant women in clinical trials, issuing a draft guidance outlining how to do so safely and ethically.

Nearly 4 million women in the U.S. give birth each year, but few drugs have been approved as safe and effective to use during pregnancy. The new guidance aims to help drug companies address those information gaps “through judicious inclusion of pregnant women in clinical trials and careful attention to potential fetal risk.”

Experts say it’s a sign of progress on an issue that’s long plagued pregnant women and their physicians.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： Medicare Advantage insurers pressure Biden for bigger payments

Wikipedia

focus

hotspot

Wikipedia

hotspot

MollyFergusonforSTATScientistsattheUniversityofWisconsin-Madisonhavespentyearstryingtounravelthedeta

WSS

Anthos stroke drug appears safer than common blood thinner

Testing GLP

CRISPR technology availability, affordability needs to be expanded

Diabetes management: Digital health tools fall short, study says

6 surprising facts about sugar

Why medical students are struggling with mental health

leisure time

Wikipedia

Wikipedia

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Surge of respiratory disease in China has likely explanation

Psychedelics group wrestles with new pharma identity

Testing GLP

DIEP, the 'gold standard' of breast reconstruction, is under threat

Adam's Take: Intra

FDA approval of Sarepta Duchenne genetic therapy gives me hope

'Patient friction coefficient' can gauge a clinical trial's patient burden

Tori Bowie and the unacceptable rates of Black maternal death

Mirador, a new biotech startup, launches with $400 million

focus

Morphosys mixed study results for blood cancer drug

Feng Zhang suggests Editas didn’t move quickly enough to find product targets

Bring on the sabbaticals for nurses

Novo Nordisk to buy Cardior, building up pipeline of heart drugs

Astellas still sees hope in its gene therapy after four deaths

CRISPR pioneers react to Casgevy, first gene

hotspot

hotspot

Wikipedia

hotspot